Ranibizumab (anti-VEGF) [CAS 347396-82-1]
Partner: MedChemexpress LLC
| CAS No: | 347396-82-1 |
| Applications: | Neuroscience-Neuromodulation |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Ranibizumab (anti-VEGF)] |
| Purity: | 98.50 |
| Description: | Ranibizumab (RG-6321) (anti-VEGF) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms (VEGF110, VEGF121, and VEGF165)[1]. Ranibizumab (anti-VEGF) slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research[1]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
